| Q40049016 | A Note on the Susceptibility of Hemophilus influenzae Type B to Bacitracin. |
| Q66899616 | A Possible Mechanism to Explain the Growth Promotion Effect of Feed Antibiotics in Farm Animals: Zinc Bacitracin Induced Cell Wall Damage in Escherichia Coli in vitro |
| Q39702976 | A bacitracin-resistant Bacillus subtilis gene encodes a homologue of the membrane-spanning subunit of the Bacillus licheniformis ABC transporter |
| Q40924758 | A dynamin-like protein involved in bacterial cell membrane surveillance under environmental stress |
| Q38653377 | A review on comparative mechanistic studies of antimicrobial peptides against archaea. |
| Q38480787 | An ERp57-mediated disulphide exchange promotes the interaction between Burkholderia cenocepacia and epithelial respiratory cells |
| Q39964243 | An antibiotic from Bacillus mesentericus. |
| Q55004281 | Analyzing AbrB-Knockout Effects through Genome and Transcriptome Sequencing of Bacillus licheniformis DW2. |
| Q60129152 | Antibiotic Material from Bacillus licheniformis (Weigmann, emend. Gibson) Active Against Species of Mycobacteria |
| Q39967275 | Antibiotics from a strain of B. subtilis; bacilipin A and B and bacilysin |
| Q80671967 | Antifungal properties of various extracts of Bacillus subtilis (Tracy strain) obtained in the bacitracin recovery process |
| Q39437901 | Ayfivin and bacitracin: resolution of crude products into similar series of peptides |
| Q36131695 | Ayfivin; extraction, purification, and chemical properties |
| Q49471796 | Bacillibactin and Bacillomycin Analogues with Cytotoxicities against Human Cancer Cell Lines from Marine Bacillus sp. PKU-MA00093 and PKU-MA00092. |
| Q40030066 | Bacillin, a New Antibiotic Substance from a Soil Isolate of Bacillus subtilis |
| Q105327138 | Bacillin, a New Antibiotic Substance from a Soil Isolate of Bacillus subtilis |
| Q72545040 | Bacitracin production by a new strain of Bacillus subtilis. Extraction, purification, and characterization |
| Q40041585 | Bacitracin: Methods of Production, Concentration, and Partial Purification, with a Summary of the Chemical Properties of Crude Bacitracin. |
| Q78614196 | Chemistry of antibiotics of clinical importance |
| Q35897918 | Chemotherapeutic drugs; a review. |
| Q76077244 | Chemotherapy and antibiotics in surgical infections |
| Q42084987 | Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes Bacteria |
| Q59791717 | Colistin Induces Susceptibility to Bacitracin |
| Q38841551 | Comparative proteomic analysis of high cell density cultivations with two recombinant Bacillus megaterium strains for the production of a heterologous dextransucrase |
| Q37835599 | Deconstructing the Chlamydial Cell Wall |
| Q38189147 | Defence against antimicrobial peptides: different strategies in Firmicutes. |
| Q38972107 | Effects of several in-feed antibiotic combinations on the abundance and diversity of fecal microbes in weaned pigs. |
| Q33527532 | Entrapment enhancement of peptide drugs in niosomes |
| Q90494307 | Epilithic Biofilms in Lake Baikal: Screening and Diversity of PKS and NRPS Genes in the Genomes of Heterotrophic Bacteria |
| Q42292484 | Genomic and molecular characterization of a novel quorum sensing molecule in Bacillus licheniformis |
| Q34258089 | Genomic characterization of the conditionally dispensable chromosome in Alternaria arborescens provides evidence for horizontal gene transfer |
| Q40431847 | High-level iron mitigates fusaricidin-induced membrane damage and reduces membrane fluidity leading to enhanced drug resistance in Bacillus subtilis |
| Q27679545 | High-resolution crystal structure reveals molecular details of target recognition by bacitracin |
| Q38980021 | History of Antibiotics Research |
| Q36343547 | Host defense antimicrobial peptides as antibiotics: design and application strategies |
| Q89966855 | Identification and characterization of antimicrobial peptide produced by indigenously isolated Bacillus paralicheniformis UBBLi30 strain |
| Q40617870 | Identification of an Antibiotic-Producing Bacterium from the Human Intestinal Tract and Characterization of Its Antimicrobial Product |
| Q55099848 | In silico exploration of Red Sea Bacillus genomes for natural product biosynthetic gene clusters. |
| Q41374365 | Induction of penicillinase by bacitracin |
| Q40963603 | Inhibition of lipid-linked saccharide synthesis by bacitracin |
| Q50416558 | Licheniformin, an Antibiotic Substance from Bacillus licheniformis, Active against Mycobacterium tuberculosis |
| Q90468101 | Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics |
| Q79548809 | Local use of bacitracin |
| Q34740721 | Macrocyclic drugs and synthetic methodologies toward macrocycles |
| Q35979390 | Mechanism of bacitracin resistance in gram-negative bacteria that synthesize exopolysaccharides |
| Q34744785 | Metal binding and structure-activity relationship of the metalloantibiotic peptide bacitracin |
| Q47434103 | Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli. |
| Q80369153 | Newer antibacterial agents in surgery |
| Q93794425 | News |
| Q40047108 | Observations on Bacteria Sensitive to, Resistant to, and Dependent upon Streptomycin |
| Q50200151 | Optimization of Inexpensive Agricultural By-Products as Raw Materials for Bacitracin Production in Bacillus licheniformis DW2. |
| Q64100543 | Overview of the Antimicrobial Compounds Produced by Members of the Group |
| Q78936900 | Polymyxin, Colistin and Bacitracin |
| Q38361614 | Regulation of the Bacillus subtilis bcrC bacitracin resistance gene by two extracytoplasmic function sigma factors. |
| Q37478671 | Requirement of divalent metal ions for bacitracin activity |
| Q90570253 | Secondary metabolite production and the safety of industrially important members of the Bacillus subtilis group |
| Q47848824 | Status of subtilin and pyocyanine as antibiotics. |
| Q40332801 | Studies on Polymyxin: Isolation and Identification of Bacillus polymyxa and Differentiation of Polymyxin from Certain Known Antibiotics. |
| Q33884427 | Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo |
| Q72373064 | Synthetic Studies of Bacitracin. I. Synthesis of a Protected Intermediate Heptapeptide (5—11) |
| Q42594370 | Systematic mutagenesis method for enhanced production of bacitracin by Bacillus licheniformis Mutant Strain UV-MN-HN-6. |
| Q40997889 | THE BLOOD LEVELS AND RENAL CLEARANCE IN RABBITS AND MAN OF AN ANTIBIOTIC DERIVED FROM B. SUBTILIS (BACITRACIN). |
| Q41843968 | THE ISOLATION OF ACTIVE PRINCIPLES IN PURE FORM BY PARTITION |
| Q35140595 | THE USE OF ANTIBIOTICS IN SURGICAL PRACTICE. |
| Q37532203 | The Action of Bacitracin and Subtilin on Treponema pallidum in Vitro and in Vivo |
| Q40038579 | The Effect of Streptococcus pyogenes Extracts and Filtrates on Various Bacteria |
| Q37203727 | The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300. |
| Q28074153 | The Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and Tunicates |
| Q37532189 | The Relative Antisyphilitic Activity of Penicillins F, G, K, and X and of Bacitracin, Based on the Amounts Required to Abort Early Syphilitic Infections in Rabbits |
| Q95819950 | The Results of the Systemic Administration of the Antibiotic, Bacitracin, in Surgical Infections: A Preliminary Report |
| Q45306734 | The Semi Large-scale Production, Extraction, Purification and Properties of an Antibiotic Produced byBacillus licheniformisStrain 2725 |
| Q34744309 | The bacitracin biosynthesis operon of Bacillus licheniformis ATCC 10716: molecular characterization of three multi-modular peptide synthetases |
| Q78970692 | The biosynthesis of D-amino acids in Bacillus licheniformis |
| Q44349831 | The chemotherapy of bacterial infections refractory to the common antibiotics |
| Q36335002 | The discovery of cell wall active antibacterial antibiotics |
| Q44820432 | The distribution and excretion of zinc bacitracin-14C in rats and swine |
| Q35424452 | The effect of bacitracin on renal function |
| Q75723124 | The treatment of infantile diarrhea with a new combination of antibiotics |
| Q42923038 | The treatment of pyogenic skin infections with bacitracin ointment. |
| Q52543153 | The two-component regulatory system BacRS is associated with bacitracin 'self-resistance' of Bacillus licheniformis ATCC 10716. |
| Q33609552 | The use of bacitracin for identifying group A haemolytic streptococci |
| Q34111992 | Topical antimicrobials for burn wound infections |
| Q40045941 | Use of antibiotics and chemotherapeutics in surgery |
| Q64106686 | Using Bioactive Glasses in the Management of Burns |
| Q34851415 | What's new in aureomycin and other antibiotics |
| Q55529318 | Whole genome sequencing and identification of Bacillus endophyticus and B. anthracis isolated from anthrax outbreaks in South Africa. |
| Q73575844 | [Bacitracin test, a simple method for determination of group A hemolytic streptococci] |
| Q78629872 | [Combined bacitracin and hemolysis inhibition test in practical group differentiation of hemolyzing streptococci] |
| Q73787391 | [Research technics in the discovery of new antibiotics] |